Haegeman G - Search Results

1

Induction and repression of NF-kappa B-driven inflammatory genes.

Vanden Berghe W, De Bosscher K, Vermeulen L, De Wilde G, Haegeman G. Vanden Berghe W, et al. Among authors: haegeman g. Ernst Schering Res Found Workshop. 2002;(40):233-78. doi: 10.1007/978-3-662-04660-9_14. Ernst Schering Res Found Workshop. 2002. PMID: 12355719 Review. No abstract available.

2

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.

De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. De Bosscher K, et al. Among authors: haegeman g. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3919-24. doi: 10.1073/pnas.97.8.3919. Proc Natl Acad Sci U S A. 2000. PMID: 10760263 Free PMC article.

3

Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G. Vermeulen L, et al. Among authors: haegeman g. Biochem Pharmacol. 2002 Sep;64(5-6):963-70. doi: 10.1016/s0006-2952(02)01161-9. Biochem Pharmacol. 2002. PMID: 12213593 Review.

4

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. Vermeulen L, et al. Among authors: haegeman g. EMBO J. 2003 Mar 17;22(6):1313-24. doi: 10.1093/emboj/cdg139. EMBO J. 2003. PMID: 12628924 Free PMC article.

5

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

De Bosscher K, Vanden Berghe W, Haegeman G. De Bosscher K, et al. Among authors: haegeman g. Endocr Rev. 2003 Aug;24(4):488-522. doi: 10.1210/er.2002-0006. Endocr Rev. 2003. PMID: 12920152 Review.

6

A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G. Vanden Berghe W, et al. Among authors: haegeman g. Adv Exp Med Biol. 2003;544:181-96. doi: 10.1007/978-1-4419-9072-3_22. Adv Exp Med Biol. 2003. PMID: 14713228 Review.

7

Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy.

Dijsselbloem N, Vanden Berghe W, De Naeyer A, Haegeman G. Dijsselbloem N, et al. Among authors: haegeman g. Biochem Pharmacol. 2004 Sep 15;68(6):1171-85. doi: 10.1016/j.bcp.2004.05.036. Biochem Pharmacol. 2004. PMID: 15313415 Review.

8

A fully dissociated compound of plant origin for inflammatory gene repression.

De Bosscher K, Vanden Berghe W, Beck IM, Van Molle W, Hennuyer N, Hapgood J, Libert C, Staels B, Louw A, Haegeman G. De Bosscher K, et al. Among authors: haegeman g. Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15827-32. doi: 10.1073/pnas.0505554102. Epub 2005 Oct 21. Proc Natl Acad Sci U S A. 2005. PMID: 16243974 Free PMC article.

9

Regulation of NF-kappaB transcriptional activity.

Vermeulen L, Vanden Berghe W, Haegeman G. Vermeulen L, et al. Among authors: haegeman g. Cancer Treat Res. 2006;130:89-102. Cancer Treat Res. 2006. PMID: 16610704 Review.

10

Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity.

Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu MN, Boone E, Haegeman G. Vanden Berghe W, et al. Among authors: haegeman g. Cancer Res. 2006 May 1;66(9):4852-62. doi: 10.1158/0008-5472.CAN-05-2957. Cancer Res. 2006. PMID: 16651441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters